(VIANEWS) – NCS Multistage Holdings (NCSM), Uber (UBER), Citizens Community Bancorp (CZWI) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NCS Multistage Holdings (NCSM)
20.2% sales growth and 14% return on equity
NCS Multistage Holdings, Inc. provides engineered products and support services for oil and natural gas well completions and construction, and field development strategies in the United States, Canada, and internationally. It offers fracturing systems, which include casing-installed sliding sleeves, downhole frac isolation assemblies, and sand jet perforating products; enhanced recovery products, such as sliding sleeve, as well as Terrus system, an injection control device; repeat precision products comprising composite frac plugs and bridge plugs, single-use disposable setting tools, express systems, and related products; chemical and radioactive tracer diagnostics services; and well construction products, including AirLock casing buoyancy system, Vecturon and Vectraset liner hanger systems, and Toe initiation sleeves. It offers its products and services primarily to exploration and production companies for use in onshore wells through technically-trained sales force, and operating partners or sales representatives. The company was formerly known as Pioneer Super Holdings, Inc. and changed its name to NCS Multistage Holdings, Inc. in December 2016. NCS Multistage Holdings, Inc. was founded in 2006 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, NCS Multistage Holdings has a trailing twelve months EPS of $5.65.
PE Ratio
NCS Multistage Holdings has a trailing twelve months price to earnings ratio of 3.03. Meaning, the purchaser of the share is investing $3.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14%.
Yearly Top and Bottom Value
NCS Multistage Holdings’s stock is valued at $17.11 at 20:22 EST, way under its 52-week high of $21.85 and way higher than its 52-week low of $12.02.
Sales Growth
NCS Multistage Holdings’s sales growth for the next quarter is 20.2%.
2. Uber (UBER)
17.5% sales growth and 15.59% return on equity
Uber Technologies, Inc. develops and operates proprietary technology applications in the United States, Canada, Latin America, Europe, the Middle East, Africa, and Asia excluding China and Southeast Asia. It operates through three segments: Mobility, Delivery, and Freight. The Mobility segment connects consumers with a range of transportation modalities, such as ridesharing, carsharing, micromobility, rentals, public transit, taxis, and other modalities; and offers riders in a variety of vehicle types, as well as financial partnerships products and advertising services. The Delivery segment allows to search for and discover restaurants to grocery, alcohol, convenience, and other retails; order a meal or other items; and Uber direct, a white-label Delivery-as-a-Service for retailers and restaurants, as well as advertising. The Freight segment manages transportation and logistics network, which connects shippers and carriers in digital marketplace including carriers upfronts, pricing, and shipment booking; and provides on-demand platform to automate logistics end-to-end transactions for small-and medium-sized business to global enterprises. The company was formerly known as Ubercab, Inc. and changed its name to Uber Technologies, Inc. in February 2011. Uber Technologies, Inc. was founded in 2009 and is headquartered in San Francisco, California.
Earnings Per Share
As for profitability, Uber has a trailing twelve months EPS of $0.87.
PE Ratio
Uber has a trailing twelve months price to earnings ratio of 86.53. Meaning, the purchaser of the share is investing $86.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.59%.
Sales Growth
Uber’s sales growth is 14.2% for the current quarter and 17.5% for the next.
Moving Average
Uber’s value is way above its 50-day moving average of $68.32 and way above its 200-day moving average of $62.67.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 66.7% and 250%, respectively.
Previous days news about Uber(UBER)
- According to Zacks on Wednesday, 26 June, "The company’s multi-year partnership with Uber Technologies (UBER Quick QuoteUBER – Free Report) to offer an autonomous driving experience to the latter’s customers in Phoenix, AZ, is a positive. "
- Uber technologies (Uber) stock dips while market gains: key facts. According to Zacks on Wednesday, 26 June, "Any recent changes to analyst estimates for Uber Technologies should also be noted by investors. ", "Looking at valuation, Uber Technologies is presently trading at a Forward P/E ratio of 84.76. "
3. Citizens Community Bancorp (CZWI)
17.2% sales growth and 7.99% return on equity
Citizens Community Bancorp, Inc. operates as a bank holding company for Citizens Community Federal N.A. that provides various traditional community banking services to businesses, agricultural operators, and consumers. The company accepts various deposit products, including demand deposits, savings and money market accounts, and certificates of deposit. It also offers various loan products comprising commercial real estate, commercial and industrial, agricultural real estate, agricultural operating, and consumer loans; and residential mortgages and home equity lines-of-credit. In addition, the company provides a portfolio of investments, such as mortgage-backed, corporate asset-backed, U.S. Government sponsored agency, corporate debt, and trust preferred securities. It operates through a network of 25 branch locations in Wisconsin and Minnesota. The company was founded in 1938 and is based in Eau Claire, Wisconsin.
Earnings Per Share
As for profitability, Citizens Community Bancorp has a trailing twelve months EPS of $1.29.
PE Ratio
Citizens Community Bancorp has a trailing twelve months price to earnings ratio of 8.81. Meaning, the purchaser of the share is investing $8.81 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.99%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 60.01M for the twelve trailing months.
4. QCR Holdings (QCRH)
9.6% sales growth and 13.24% return on equity
QCR Holdings, Inc., a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services. Its deposit products include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. The company also provides various commercial and retail lending/leasing, and investment services to corporations, partnerships, individuals, and government agencies. Its loan portfolio comprises loans to small and mid-sized businesses; business loans, including lines of credit for working capital and operational purposes; term loans for the acquisition of facilities, equipment, and other purposes; commercial and residential real estate loans; and installment and other consumer loans, such as home improvement, home equity, motor vehicle, and signature loans, as well as small personal credit lines. In addition, the company engages in leasing of machinery and equipment to commercial and industrial businesses under direct financing lease contracts; and issuance of trust preferred securities. It serves the Quad Cities, Cedar Rapids, Cedar Valley, Des Moines/Ankeny, and Springfield communities. The company was founded in 1993 and is headquartered in Moline, Illinois.
Earnings Per Share
As for profitability, QCR Holdings has a trailing twelve months EPS of $6.71.
PE Ratio
QCR Holdings has a trailing twelve months price to earnings ratio of 8.29. Meaning, the purchaser of the share is investing $8.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.24%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.2%, now sitting on 337.02M for the twelve trailing months.
5. Kamada Ltd. (KMDA)
6.8% sales growth and 5.9% return on equity
Kamada Ltd., together with its subsidiaries, provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; VARIZIG for post exposure prophylaxis of varicella; and GLASSIA for intravenous AATD. It also provides KamRho (D) IM for prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN for Allergic rhinitis and Urticaria; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for cytomegalovirus virus; RUCONEST for angioedema attacks; heparin sodium injection for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. Further, it offers IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; and ELIGARD for prostate cancer. The company markets its products through strategic partners in the United States, as well as through distributors internationally. It has strategic partnerships with Takeda Pharmaceuticals Company Limited; PARI GmbH; and Kedrion Biopharma. Kamada Ltd. was incorporated in 1990 and is headquartered in Rehovot, Israel.
Earnings Per Share
As for profitability, Kamada Ltd. has a trailing twelve months EPS of $0.23.
PE Ratio
Kamada Ltd. has a trailing twelve months price to earnings ratio of 20.78. Meaning, the purchaser of the share is investing $20.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.9%.
Moving Average
Kamada Ltd.’s worth is under its 50-day moving average of $5.27 and way below its 200-day moving average of $5.40.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.9%, now sitting on 149.54M for the twelve trailing months.
Volume
Today’s last reported volume for Kamada Ltd. is 22492 which is 27.31% above its average volume of 17667.
6. HealthStream (HSTM)
5.2% sales growth and 5.23% return on equity
HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
Earnings Per Share
As for profitability, HealthStream has a trailing twelve months EPS of $0.58.
PE Ratio
HealthStream has a trailing twelve months price to earnings ratio of 47.76. Meaning, the purchaser of the share is investing $47.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.23%.
Volume
Today’s last reported volume for HealthStream is 277708 which is 155.99% above its average volume of 108483.
Sales Growth
HealthStream’s sales growth is 5.3% for the present quarter and 5.2% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 7.7% and a negative 7.7%, respectively.
Moving Average
HealthStream’s value is higher than its 50-day moving average of $26.67 and above its 200-day moving average of $25.57.
